SEI Investments’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$952K Sell
165,045
-192,843
-54% -$978K ﹤0.01% 2319
2026
Q1
$1.77M Buy
+357,888
New +$1.74M ﹤0.01% 2068

Other funds holding SOPH

SEI Investments's SOPH Position: Q2 2026 in Review

SEI Investments reduced its SOPHiA GENETICS (SOPH) stake by 54% in Q2 2026, selling an estimated $978K and leaving 165,045 shares worth $952K. The position accounts for ﹤0.01% of the portfolio, ranked #2319.

SEI Investments first reported a position in SOPH in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.77M in Q1 2026. 72 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.

  • SEI Investments held 165,045 shares of SOPHiA GENETICS worth $952K as of Q2 2026.
  • SEI Investments sold 192,843 SOPHiA GENETICS shares in Q2 2026, an estimated $978K.
  • SOPHiA GENETICS made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2319 holding.
  • SEI Investments first reported a position in SOPHiA GENETICS in Q1 2026 and has held it in 2 quarters since.
  • SEI Investments's SOPHiA GENETICS position peaked at $1.77M in Q1 2026.
  • 72 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.